Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.
暂无分享,去创建一个
B. Graham | F. Sinangil | J. Esterlitz | T. Matthews | K. Weinhold | P. Fast | G. Gorse | M. Keefer | D. Schwartz | M. McElrath